Viewing Study NCT00096395


Ignite Creation Date: 2025-12-24 @ 2:06 PM
Ignite Modification Date: 2026-01-04 @ 6:36 PM
Study NCT ID: NCT00096395
Status: COMPLETED
Last Update Posted: 2013-06-13
First Post: 2004-11-09
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Sorafenib Tosylate and Gemcitabine Hydrochloride in Treating Patients With Recurrent Epithelial Ovarian Cancer
Sponsor: National Cancer Institute (NCI)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module